Don’t miss SMi’s 4th annual Managing Partnerships with CROs conference that will provide delegates with a comprehensive overview and analysis of outsourcing in the pharmaceutical sector, offering the unique opportunity to hear from representatives from Pharma, CRO and Academia with an emphasis on improving communication and creating strong and successful partnerships between all parties. Key benefits of attending: Learn from industry specialists what current issues are facing those working within sponsor CRO relationships. Understand what causes breakdown in relationships and ways to prevent this through real case studies. Hear from speakers on both sides of the relationship, and their strategies…

The 1st Asia-Pacific Glaucoma Congress (APGC 2012) is now the only regional glaucoma meeting. Tailored for ophthalmologists, eye surgeons, vision scientists and other professionals with an interest in glaucoma, APGC 2012 will serve as a natural gathering point for both experienced and young professionals to present their research, take part in hands-on instructional courses, and network with the best and brightest minds in the field today.

Prevention is better than cure. This year’s event will deliberately address the prevention strategies against the globally important health problem of cardiovascular health disease with special emphasis on the control of various risk factors namely hypertension, hyperlipidaemia, smoking, diabetes mellitus and obesity. There will also be updates on the various pharmacological advancement in the field of preventive cardiology.

The combined share of prescription drug spending in the US and Europe will shrink from 61% in 2005 to 44% by 2015. At the same time, spending in the emerging markets will grow from 12% in 2005 to 28% by 2015. - IMS Health report, 2011 With prolonged global economic crises and slowdown in the West, companies are increasingly looking towards the emerging markets. With a rapidly expanding, affluent (and ageing) population demanding greater access to affordable safe medicines, coupled with rising spending power, Southeast Asia presents the next growth area. While China and India have grabbed the attention of…

The 2013 Congress will bring psychiatrists and other discipline-related professionals together to address the complex theme of ‘Europe challenges the burden on mental disorders’.

IAPT for Severe Mental Illness Shaping the future: Improving access to psychological therapies for people with severe mental illness Do you want to hear direct from the IAPT National Advisor for SMI about how IAPT is evolving to meet the needs of people with severe mental illness? Yes? Then this event is for you. The programme to extend IAPT for people with severe mental illness is at an early stage, so that’s why we’ve put together a seminar packed with opportunities for discussion and debate, chaired by Alex Stirzaker, the IAPT National Advisor for SMI. As well as hearing from…

Veteran Engagement in Mental Health Services Improve IAPT and non-IAPT mental health outcomes for veterans: learn from the UK’s most innovative services The Department of Health have made improving mental health services for Armed Forces' veterans a priority for the NHS in the coming years. Whether you are an NHS professional seeking new ideas and innovations for an existing veterans’ service, looking to access funding to set up a new service, or simply keen to hear best practice from the UK’s leading veterans’ mental health programmes, this event is for you. This is the only seminar of its kind to…

Driving Forward your Nuclear Medicine Service Leaders in NHS Nuclear Medicine: what should you be challenging in your service delivery? Discover practical techniques to improve nuclear medicine services and deliver savings This one day conference has been designed to give you the opportunity to share, learn and take away the tools you need to implement change and drive forward your nuclear medicine services. This is your chance to hear the latest advances, exchange best practice, listen to innovative case studies and network with your peers to face your day to day challenges. Click here to view the programme agenda for…

Driving Forward your Nuclear Medicine Service Leaders in NHS Nuclear Medicine: what should you be challenging in your service delivery? Discover practical techniques to improve nuclear medicine services and deliver savings This one day conference has been designed to give you the opportunity to share, learn and take away the tools you need to implement change and drive forward your nuclear medicine services. This is your chance to hear the latest advances, exchange best practice, listen to innovative case studies and network with your peers to face your day to day challenges. Click here to view the programme agenda for…

How to Set up a Practitioner Led Nuclear Medicine Service Calling all Radiographers and Technologists: Deliver a safe, cost effective new service Your guide to the set up and sustainment of Radiographer and Technologist led reporting: A practical interactive seminar for NHS Nuclear Medicine professionals, designed to enable you to deliver a financially viable, efficient and quality practitioner led service. This is an unmissable opportunity to get to grips with the principles and practicalities of setting up a practitioner led service in your Nuclear Medicine department. Packed with examples and best practice guidance this crucial one day training seminar will…

How to Develop a Robust Clinical Research Financial Management System Implement and improve your financial processes for clinical research: develop the financial management structures that are right for your site. You have secured the clinical trial at your site – now what? Attracting clinical research is only half the story. You need to be able to manage the income and costs that are derived from clinical research in order for it to have any financial value for your site. Do you need to develop rigorous financial processes for your clinical research? Yes?! Book on to this dedicated clinical research study…

Compliance Guide to Data Sharing, Data Protection, Confidentiality and Consent for Clinical Research Designed for Clinical Research Professionals charged with managing patient data: Information sharing is an increasing area of scrutiny and concern for clinical research. This dedicated guide will enable you to find out how you can design processes and protocols, have your questions answered and return to your organisation confident that you are compliant. As a clinical research professional, information governance can seem like a cumbersome area of your responsibilities, but it is vitally important and the penalties for getting it wrong are significant. To help you manage…

POCT Service Growth: a signpost event to help direct you on your POCT service journey Increase your awareness of the POCT solutions available, and how to get the trust and community interested in using POCT. By sharing initiatives on how other POCT co-ordinators are running their services and experience from around the country of good systems, you can improve on the implementation and control your POCT. • CONTENT: From idea to the cost-benefit business case, commissioning to implementation, managing resources and controlling the quality and delivering the service • BENEFIT: If you want to forge your service ahead then this…

How to Deliver POCT in a Managed Service Contract: follow the formulation, set-up and tender of an example managed service contract for POCT. You can delve into the detail of the model to ensure the contract you put together reflects what you want and allows for flexibility to add further tests later. This interactive forum will enlighten you on how to get the greatest benefit from this arrangement rather than just using it as a tax efficient means of purchase. Do you want to know how to deliver POCT within a managed service contract? Yes? Then this scenario based learning…

Being up-to-date with current requirements and understanding individual authority interpretation of guidelines is critical for successful product registration. The challenge in Asia is the frequency of changing regulations and increasing time-lag for regulatory approval – factors which can significantly impact on your time to market and bottom line. IBC’s Pharmaceutical Regulatory Asia Summit is the longest standing event of its kind in the region. In our 5 th year, we are emphasizing collaborations between industry and authority to expedite the approval of safe and effective drugs. In this event you will not be presented with a series of regulatory checklists…

Overview: This course will present, in one place, the regulations and guidelines that apply to early phase products. In some cases these will not be regulations, but needs that, if met, will increase the efficiency of activities as a product proceeds through the development process. The course will present these items in the order of product development from the point of R & D activities to the completion of Phase 2 clinical trials. Why should you attend: Any pharmaceutical worker who must deal with products both in early and latter phases of development should attend this course in order to…

IMMUNO2013 is a leading immunosuppression conference that provides researchers and practitioners with the latest developments in the fields of Immunosuppression, Immunomodulation and Immunotherapy. The conference will facilitate networking, the exchange of knowledge, and opportunities to learn from world experts.

The 10th International Congress on Coronary Artery Disease (ICCAD 2013) is a CME-accredited forum aimed at researchers and clinical practitioners in cardiovascular disease. ICCAD gatherings have developed a well-earned reputation for providing participants with a platform to exchange ideas relating to coronary artery disease.

Join world-renowned experts for the most advanced research and techniques in gynecologic cancer patient care.

This 90-minute webinar will discuss the new FDA "Global Engagement" Initiative for new areas for heightened CGMP compliance from U. S. FDA-regulated companies and their global partners. It will cover areas for increased awareness, focus, and remediation, and the approaches that are now mandated. Why Should You Attend:- The last two years have seen major initiatives at the FDA; as well as prominent drug and device failures over cGMP issues, resulting in recalls, lawsuits, class action lawsuits, and even possible criminal prosecution. The FDA sees globalization as a growing reality, and potential contributor of major regulatory issues: the supply chain,…